Kristien Boelaert

91 - 100 out of 168Page size: 10

Publications

  1. Published

    Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.

    Christopher McCabe, Kristien Boelaert, Lesley Tannahill, Shakir Hussain, Michael Sheppard, Jayne Franklyn & Neil Gittoes, 1 Feb 2003, In : Clinical Endocrinology. 58, 2, p. 141-50 10 p.

    Research output: Contribution to journal › Article

  2. Published

    The destruction box of pituitary tumor transforming gene (PTTG) mediates cell transformation in vitro

    Christopher McCabe, Jattinder Khaira, Kristien Boelaert, Lesley Tannahill, Michael Sheppard, Jayne Franklyn & Neil Gittoes, 1 Jan 2001, p. OR37-2.

    Research output: Contribution to conference (unpublished) › Paper

  3. Published

    Expression and function of VEGF and its receptor KDR in pituitary tumors

    Christopher McCabe, Kristien Boelaert, Lesley Tannahill, Michael Sheppard, Neil Gittoes & Jayne Franklyn, 1 Jan 2002, p. P2-231.

    Research output: Contribution to conference (unpublished) › Paper

  4. Published

    Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors

    Christopher McCabe, Kristien Boelaert, Lesley Tannahill, Jattinder Khaira, Michael Sheppard, Jayne Franklyn & Neil Gittoes, 1 Sep 2002, In : Journal of Clinical Endocrinology and Metabolism. 87, 9, p. 4238-4244 7 p.

    Research output: Contribution to journal › Article

  5. Published

    The destruction box PTTG mediates cell transformation

    Christopher McCabe, Lesley Tannahill, Kristien Boelaert, Michael Sheppard, Jayne Franklyn & Neil Gittoes, 1 Jan 2002, p. P139.

    Research output: Contribution to conference (unpublished) › Paper

  6. Published

    Pituitary tumor transforming gene (PTTG), PTTG binding factor (PBF) and related growth factor expression in sporadic pituitary tumours

    Christopher McCabe, Jattinder Khaira, Kristien Boelaert, Lesley Tannahill, Michael Sheppard, Jayne Franklyn & Neil Gittoes, 1 Jan 2001, p. OC18.

    Research output: Contribution to conference (unpublished) › Abstract

  7. Published

    Expression and function of VEGF and its receptor in pituitary tumours

    Christopher McCabe, Kristien Boelaert, Lesley Tannahill, Jattinder Khaira, Michael Sheppard, Neil Gittoes & Jayne Franklyn, 1 Jan 2002, p. OC14.

    Research output: Contribution to conference (unpublished) › Paper

  8. Published

    Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up

    Hisham Mehanna, Ben Carter, Kristien Boelaert & Jayne Franklyn, Aug 2014, In : The Journal of clinical endocrinology and metabolism. 99, 8, p. 2834-43 10 p.

    Research output: Contribution to journal › Article

  9. Published

    Costs and benefits of iodine supplementation for pregnant women in a mildly to moderately iodine-deficient population: a modelling analysis

    Mark Monahan, Kristien Boelaert, Kate Jolly, Shiaoyng Chan, Pelham Barton & Tracy Roberts, Sep 2015, In : The Lancet Diabetes and Endocrinology. 3, 9, p. 715-722 8 p.

    Research output: Contribution to journal › Article

  10. Published

    Thyroid stimulating hormone in thyroid cancer: does it matter?

    Hannah Nieto & Kristien Boelaert, 1 Nov 2016, In : Endocrine-related cancer. 23, 11, ERC-16-0328.

    Research output: Contribution to journal › Article

Previous 1...6 7 8 9 10 11 12 13 ...17 Next